US 6825323
Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same
expired A61KA61K38/36
Quick answer
US patent 6825323 (Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K38/36